Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Neurocrine Biosciences Posts Sizzling Sales Growth in Q2

TheMotleyFool

0 0

Neurocrine Biosciences Posts Sizzling Sales Growth in Q2Photo, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Neurocrine Biosciences (NASDAQ: NBIX) shareholders should be pleased with the stock so far in 2019. The biotech's share price is up more than 30% year to date. And it reported solid revenue growth in its first-quarter results announced in April.

Anyone wondering if Neurocrine could keep the momentum going got a strong affirmative when the company announced its second-quarter results after the market closed on Monday. It again delivered a solid performance.

Image source: Getty Images.

Quelle Fool.com

Like: 0

NBIX

Teilen